Atlas Trials

Efficacy of Remission-induction Regimen With Infliximab for Severe Extrathoracic Sarcoidosis (EFIRTES)

Clinical trial NCT03704610 · COMPLETED

Trial details

NCT number
NCT03704610
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Extrathoracic Sarcoidosis
Start date
2019-03-28
Primary completion
2021-06-21
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.